These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Genetics and the potential for predictive tests in adverse drug reactions. Pirmohamed M Chem Immunol Allergy; 2012; 97():18-31. PubMed ID: 22613851 [TBL] [Abstract][Full Text] [Related]
10. T-cell receptor and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: understanding a hypersensitivity reaction. Ko TM; Chen YT Expert Rev Clin Immunol; 2012 Jul; 8(5):467-77. PubMed ID: 22882221 [TBL] [Abstract][Full Text] [Related]
11. Immunogenetics of drug-induced skin blistering disorders. Part I: Perspective. Bowman C; Delrieu O Pharmacogenomics; 2009 Apr; 10(4):601-21. PubMed ID: 19374517 [TBL] [Abstract][Full Text] [Related]
12. Abacavir hypersensitivity: a model system for pharmacogenetic test adoption. Lai-Goldman M; Faruki H Genet Med; 2008 Dec; 10(12):874-8. PubMed ID: 19092439 [TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics of abacavir hypersensitivity: A systematic review and meta-analysis of the association with HLA-B*57:01. Sousa-Pinto B; Pinto-Ramos J; Correia C; Gonçalves-Costa G; Gomes L; Gil-Mata S; Araújo L; Delgado L J Allergy Clin Immunol; 2015 Oct; 136(4):1092-4.e3. PubMed ID: 25934581 [No Abstract] [Full Text] [Related]
14. Pharmacogenetic determinants of immediate and delayed reactions of drug hypersensitivity. Guéant JL; Guéant-Rodriguez RM; Gastin IA; Cornejo-García JA; Viola M; Barbaud A; Mertes PM; Blanca M; Romano A Curr Pharm Des; 2008; 14(27):2770-7. PubMed ID: 18991696 [TBL] [Abstract][Full Text] [Related]
15. The convenience of flow cytometry for HLA-B*5701 screening to prevent abacavir hypersensitivity reactions. Airo P; Scarsi M; Malagoli A; Carella G; Izzo I; Carosi G; Torti C J Acquir Immune Defic Syndr; 2009 Jul; 51(3):361-2. PubMed ID: 19553774 [No Abstract] [Full Text] [Related]
16. Pharmacogenomics testing for type B adverse drug reactions to anti-infective drugs: the example of hypersensitivity to abacavir. Agundez JA; Esguevillas G; Amo G; Garcia-Martin E Recent Pat Antiinfect Drug Discov; 2014; 9(2):151. PubMed ID: 25891395 [No Abstract] [Full Text] [Related]
17. HLAs: Key regulators of T-cell-mediated drug hypersensitivity. Redwood AJ; Pavlos RK; White KD; Phillips EJ HLA; 2018 Jan; 91(1):3-16. PubMed ID: 29171940 [TBL] [Abstract][Full Text] [Related]
18. Foreword. Drug allergy and primum non-nocere. Alam R Immunol Allergy Clin North Am; 2009 Aug; 29(3):xiii-xiv. PubMed ID: 19563986 [No Abstract] [Full Text] [Related]
19. New genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivity. Pirmohamed M; Ostrov DA; Park BK J Allergy Clin Immunol; 2015 Aug; 136(2):236-44. PubMed ID: 26254050 [TBL] [Abstract][Full Text] [Related]
20. HLA-B*5701 screening for susceptibility to abacavir hypersensitivity. Lucas A; Nolan D; Mallal S J Antimicrob Chemother; 2007 Apr; 59(4):591-3. PubMed ID: 17317695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]